Clinical mental health diagnoses among anabolic-androgenic steroid consumers classified as low-risk or hazardous drinkers: a brief report
Alcohol and Alcoholism · 13.05.2026 · 61 (4)
DOI: 10.1093/alcalc/agag047 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alcohol and Alcoholism, online erschienen am 09.07.2026. Verfasst von Benjamin Bonenti und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland, Level 2, Public Health Building (Buildin…. Hauptthemen laut MEDLINE: Anabolic Androgenic Steroids, Mental Disorders, Alcohol Drinking, Substance-Related Disorders. Die Arbeit nennt 26 Literaturangaben. Gefördert von: National Health and Medical Research Council Investigator Grant, Australian Research Council Discovery Early Career Researcher Award.
Abstract (Originalsprache)
Alcohol is commonly used alongside anabolic-androgenic steroids (AAS), yet its relationship with mental health in this population remains poorly understood. Among people reporting recent AAS use, hazardous drinkers reported higher prevalence of multiple psychiatric diagnoses than low-risk drinkers, particularly mood, anxiety, trauma-related, and psychotic conditions. These associations remained after adjustment for past 12-month use of other drugs beyond alcohol and AAS. Alcohol-risk level may therefore help identify AAS consumers who require more comprehensive mental health assessment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Public Health, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland, Level 2, Public Health Building (Building 887), 288 Herston Road, Herston, QLD 4006, Australia.
- School of Applied Psychology, Griffith University, Level 7, Ian O'Connor Building (G40), Parklands Drive, Southport, QLD 4222, Australia.
- Centre for Psychological Research, School of Psychology, Social Work and Public Health, Oxford Brookes University, Headington Campus, Gipsy Lane, Headington, Oxford, OX3 0BP, United Kingdom.
- University College London, Gower Street, London, WC1E 6BT, United Kingdom.
- School of Psychology, Queen's University Belfast, David Keir Building, 18-30 Malone Road, Belfast, BT9 5BN, United Kingdom.
- Research Group on Treatment and Addiction, Tampere University, Linna Building, Kalevantie 5, FI-33014 Tampere University, Tampere, Finland.
ORCID-Profile: Benjamin Bonenti, Cheneal Puljévic, Jason Ferris, Emma Davies, Jason M Nagata, Timothy Piatkowski
Förderung
- National Health and Medical Research Council Investigator Grant
- Australian Research Council Discovery Early Career Researcher Award
Zitieren
APA
Bonenti, B., Puljévic, C., Ferris, J., Davies, E., Winstock, A., Shorter, G. W., Ganson, K., Barnett, A., Nagata, J. M., & Piatkowski, T. (2026). Clinical mental health diagnoses among anabolic-androgenic steroid consumers classified as low-risk or hazardous drinkers: a brief report. Alcohol and Alcoholism, 61(4). https://doi.org/10.1093/alcalc/agag047
Vancouver
Bonenti B, Puljévic C, Ferris J, Davies E, Winstock A, Shorter GW, et al. Clinical mental health diagnoses among anabolic-androgenic steroid consumers classified as low-risk or hazardous drinkers: a brief report. Alcohol and Alcoholism. 2026;61(4). doi:10.1093/alcalc/agag047
BibTeX
@article{Bonenti2026,
author = {Bonenti, Benjamin and Puljévic, Cheneal and Ferris, Jason and Davies, Emma and Winstock, Adam and Shorter, Gillian W and Ganson, Kyle and Barnett, Anthony and Nagata, Jason M and Piatkowski, Timothy},
title = {Clinical mental health diagnoses among anabolic-androgenic steroid consumers classified as low-risk or hazardous drinkers: a brief report},
journal = {Alcohol and Alcoholism},
year = {2026},
volume = {61},
number = {4},
doi = {10.1093/alcalc/agag047}
}
EUVIMED